Owing to the small sample size, we were not able to correct the values for confounding factors also known to increase FGF21 levels, such as type 2 diabetes or NAFLD (35, 36, 37, 38, 39). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.